PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $37,000 | -47.1% | 9,750 | -29.1% | 0.00% | – |
| Q4 2019 | $70,000 | 0.0% | 13,750 | 0.0% | 0.00% | – |
| Q3 2019 | $70,000 | -27.8% | 13,750 | -12.7% | 0.00% | -100.0% |
| Q2 2019 | $97,000 | +32.9% | 15,750 | 0.0% | 0.00% | – |
| Q1 2019 | $73,000 | +10.6% | 15,750 | 0.0% | 0.00% | – |
| Q4 2018 | $66,000 | -4.3% | 15,750 | +43.2% | 0.00% | – |
| Q3 2018 | $69,000 | +32.7% | 11,000 | +69.2% | 0.00% | – |
| Q2 2018 | $52,000 | -32.5% | 6,500 | -36.9% | 0.00% | -100.0% |
| Q1 2018 | $77,000 | +156.7% | 10,300 | +106.0% | 0.00% | – |
| Q4 2017 | $30,000 | -18.9% | 5,000 | 0.0% | 0.00% | – |
| Q3 2017 | $37,000 | +8.8% | 5,000 | 0.0% | 0.00% | – |
| Q2 2017 | $34,000 | -27.7% | 5,000 | 0.0% | 0.00% | – |
| Q1 2017 | $47,000 | +9.3% | 5,000 | 0.0% | 0.00% | – |
| Q4 2016 | $43,000 | +34.4% | 5,000 | 0.0% | 0.00% | – |
| Q3 2016 | $32,000 | +52.4% | 5,000 | 0.0% | 0.00% | – |
| Q2 2016 | $21,000 | -4.5% | 5,000 | 0.0% | 0.00% | – |
| Q1 2016 | $22,000 | -29.0% | 5,000 | 0.0% | 0.00% | – |
| Q4 2015 | $31,000 | +6.9% | 5,000 | 0.0% | 0.00% | – |
| Q3 2015 | $29,000 | -21.6% | 5,000 | 0.0% | 0.00% | – |
| Q2 2015 | $37,000 | +23.3% | 5,000 | 0.0% | 0.00% | – |
| Q1 2015 | $30,000 | -21.1% | 5,000 | 0.0% | 0.00% | – |
| Q4 2014 | $38,000 | +46.2% | 5,000 | 0.0% | 0.00% | – |
| Q3 2014 | $26,000 | +18.2% | 5,000 | -0.6% | 0.00% | – |
| Q2 2014 | $22,000 | +10.0% | 5,030 | +0.6% | 0.00% | – |
| Q1 2014 | $20,000 | -25.9% | 5,000 | 0.0% | 0.00% | – |
| Q4 2013 | $27,000 | -3.6% | 5,000 | -9.1% | 0.00% | – |
| Q3 2013 | $28,000 | +27.3% | 5,500 | +10.0% | 0.00% | – |
| Q2 2013 | $22,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|